Navigation Links
Microbix Announces A New Technology Platform For The SST Project
Date:4/7/2009

having identified specific proteins and associated monoclonal antibodies that differentiated these cells, and the Company submitted a provisional patent on the discovery.

Subsequent work led to the recognition that the family of proteins required additional investigation. In a release in February 2008 the Company announced expansion of the SST development program to fully evaluate proteins to respectively characterize X and Y chromosome-bearing sperm. New state-of-the-art technologies were brought to bear on the analysis and the commercial potential of these discoveries. We have now completed this work and our evaluation of the proteins has not pointed to a commercial utility thus far.

However, this work has led to the discovery of a lower risk and commercially attractive next generation technology to achieve the same objective. Accordingly, broad patent claims protecting this technology are being filed. Field trials demonstrating the commercial application of this next-generation technology are expected to occur pending financing. The Company will provide an updated guidance on the timeline.

"The Scientific Advisory Committee has conducted a thorough review of all the results and methodologies associated with this program," said Dr. Mark A. Cochran, Chair of the committee. "We are very confident that the data generated strengthen the technological position of Microbix for the next phase of the work."

"The extensive scientific review we have undertaken has clearly concluded that we have met the research objectives of the SST program," said Mr. Gastle. "Product development now moves in a new direction to complete the commercial delivery platform for the AI industry."

Microbix specializes in the development of biological technologies and commercializing them through global partners. The Company has intellectual property in large market biotherapeutic drugs, vaccine technologies and animal reproduction technologies. Est
'/>"/>

SOURCE Microbix Biosystems Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Microbix First Quarter Sales Grow Over 50% With Continued Progress On The Pipeline
2. Microbix Uses Core Business Cashflow To Fund Late-Stage Pipeline To Build Shareholder Value In 2009
3. ImaRx Therapeutics Signs Letter of Intent With Microbix Biosystems for the Sale of Urokinase
4. Oncolytics Biotech(R) Inc. Announces Positive Results of U.K. Phase II REOLYSIN(R) and Radiation Combination Clinical Trial
5. Caliper Life Sciences Announces Date and Location of its 2009 Annual Meeting of Stockholders
6. Immunotech Laboratories Announces South American Strategy
7. Siemens Healthcare Announces Planned Collaboration with Harris Corporation
8. ChromaDex Announces 2008 Year End Financial Results
9. China Agri-Business Announces 2008 Operating Results
10. Verenium Announces Organizational Changes
11. ThermoGenesis Announces Abstracts to Be Presented at Upcoming Stem Cell Therapy Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... (PRWEB) December 17, 2014 Based ... the overall surgical imaging market is dominated by ... the surgical imaging market. These players include GE ... Ziehm Imaging (Germany). , Full Report Copy ... of GE Healthcare can be attributed to its ...
(Date:12/17/2014)... CA (PRWEB) December 17, 2014 Once ... to provide a larger packaged waste water treatment plant ... King Abdullah Economic City (KAEC). Two years ago Bioshaft ... Jeddah Gate Development, serving two residential towers with an ... is over a quarter million gallons per day and ...
(Date:12/17/2014)... San Diego, CA (PRWEB) December 17, 2014 ... strategy and activation agency and member of the Huntsworth ... Jamie Gonzales to its executive team. In her role, ... Services. , “We are incredibly honored to welcome ... said Agency Chief and CEO, Gaëtan Fraikin. “She is ...
(Date:12/17/2014)... , Dec. 17, 2014 Tigercat ... Phase 2 study evaluating the investigational oral NK-1 ... patients with severe, chronic itch who are unresponsive ... care, including topical steroids and antihistamines. ... in Visual Analog Scale (VAS) itch score from ...
Breaking Biology Technology:Global Refurbished Surgical Imaging Market by Product & Application is Estimated to Reach $1.25 Billion by 2019 - New Research Report by MarketsandMarkets 2Global Refurbished Surgical Imaging Market by Product & Application is Estimated to Reach $1.25 Billion by 2019 - New Research Report by MarketsandMarkets 3Global Refurbished Surgical Imaging Market by Product & Application is Estimated to Reach $1.25 Billion by 2019 - New Research Report by MarketsandMarkets 4Audacity Welcomes Healthcare Communications Expert Jamie Gonzales as Senior Vice President of Client Services 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4
... 13 Nektar Therapeutics,(Nasdaq: NKTR ) announced ... clinical,trial of NKTR-102 in platinum-resistant ovarian cancer. Regulatory ... in two additional,trials: a randomized Phase 2 study to ... the KRAS gene mutation, and a,Phase 2 study in ...
... /PRNewswire-FirstCall/ - GeneNews Limited (TSX: GEN), a company ... early detection of diseases and personalized health management, ... # 7,473,528 entitled "Method for the detection of ... patent protects the Company,s discovery of a blood ...
... the healthcare industry creates growth opportunities for healthcare ... 13 The credit crisis and the global ... in the Healthcare industry in 2009. Healthcare in ... as the developed countries.(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO )Dr. Louis ...
Cached Biology Technology:First Patient Dosed in Phase 2 Clinical Trial of NKTR-102 in Ovarian Cancer 2First Patient Dosed in Phase 2 Clinical Trial of NKTR-102 in Ovarian Cancer 3First Patient Dosed in Phase 2 Clinical Trial of NKTR-102 in Ovarian Cancer 4GeneNews granted U.S. patent for Chagas disease based on Sentinel Principle(TM) platform 22009 is Healthy for Asia 22009 is Healthy for Asia 3
(Date:12/17/2014)... 15, 2014 The Defense Logistics Agency ... to detect and prevent counterfeit microcircuits from entering ... agency started performing an in-house microcircuit anti-counterfeit initiative ... authenticity of purchased microcircuits while increasing their reliability ... measures will be conducted at DLA,s Electronics Product ...
(Date:12/17/2014)... 2014 Valencell, a leader in performance biometric ... to industry leaders such as Intel, Jabra, Atlas, and ... wearable products. These products will be showcased at CES ... Vegas . "Our partners choose ... robust – with the clinical data to back it ...
(Date:12/17/2014)...  Automation is fundamentally transforming the travel experience ... international borders. Over the past decade, ePassports, biometric ... travelers to self process through border control via ... an increasing number of airports, seaports, and land ... to Maxine Most , Principal at Acuity ...
Breaking Biology News(10 mins):Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2
... Like coal-mine canaries, fish DNA can serve as a ... pollution--or pollution clean-up. That's one of the conclusions of ... Research Institute (PNRI), Woods Hole Oceanographic Institution, the University ... Technology (NIST). , Research over the past several years ...
... Brookhaven National Laboratory, the New York Structural Biology ... atomic crystal structure and functional mechanism of an ... as drugs, industrial chemicals, and toxic compounds from ... help scientists understand how these compounds are eliminated ...
... designed to build scientific understanding of fruit genes ... are created. , Researchers at New Zealand-based life ... science of gene discovery to such a degree ... create the individual flavours and fragrances found in ...
Cached Biology News:Precision biochemistry tracks DNA damage in fish 2Scientists take 'snapshots' of enzyme action 2Science captures the essence of fruit 2Science captures the essence of fruit 3
ID clarifier: platform...
The sealed ice cooling unit is used to absorb heat that is generated during transfers performed in the Criterion blotter....
... Tetrad 2 thermal cycler accommodates a ... heat-pump assemblies), which hold different types ... computer drives an advanced graphical interface ... lid temperatures. Peltier heat pumps, built ...
The SVT3-2 diverter valve is a 3-port, 2-position valve for use with the BioLogic DuoFlow system....
Biology Products: